Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074
Joon H. Uhm, Karla V. Ballman, Wenting Wu, Caterina Giannini, J.C. Krauss, Jan C. Buckner, C.D. James, Bernd W. Scheithauer, Robert J. Behrens, Patrick J. Flynn, Paul L. Schaefer, Shaker R. Dakhill, KVolume:
80
Year:
2011
Language:
english
Pages:
7
DOI:
10.1016/j.ijrobp.2010.01.070
File:
PDF, 210 KB
english, 2011